See the valve and the aorta as one decision.

It is an independent review of the records and imaging behind a bicuspid aortic valve decision. The review can organize valve morphology and function, stenosis or regurgitation, the aortic root and ascending aorta, change over time, the treatment or surveillance plan proposed, and the questions that remain. It does not diagnose or choose treatment for you.

No. Some bicuspid valves function well and are monitored, while others develop stenosis, regurgitation, or associated aortic enlargement that may lead to a treatment discussion. Symptoms, valve severity, ventricular response, aortic dimensions and growth, other health conditions, and the complete clinical context all matter. Follow the surveillance and urgent-care instructions from your treating team.

Stenosis means the valve has become too narrow for blood to leave the heart normally. Regurgitation means the valve does not close completely and blood leaks backward. A patient can also have mixed disease. The measurements, effects on the heart, timing questions, and procedural options are not identical, so the review separates them rather than treating “bicuspid” as one uniform problem.

Bicuspid aortic valve can occur with enlargement of the aortic root or ascending aorta. That may affect surveillance, imaging, and the scope or timing of a surgical conversation, especially when valve treatment is also being considered. A useful review identifies where each measurement was taken, how it was obtained, whether body-size indexing is relevant, and how it compares with prior studies.

Some bicuspid valves may be considered for repair, particularly selected regurgitant valves with favorable leaflet and root anatomy. Repairability and durability depend on the mechanism of leakage, tissue quality, cusp geometry, aortic anatomy, and repair-specific surgical experience. The review can explain whether repair deserves discussion based on the available imaging; the treating valve team determines candidacy.

TAVR may be considered for selected patients with bicuspid aortic stenosis, but bicuspid anatomy requires individualized evaluation. CT findings such as calcium pattern, annular shape, coronary relationships, and aortic dimensions, along with age, surgical risk, longevity, and future-procedure planning, affect the discussion. TAVR does not repair an enlarged root or ascending aorta and is not a treatment for every form of bicuspid valve disease.

When valve replacement is relevant, the report can organize the documented trade-offs among mechanical and tissue prostheses and, when clinically appropriate to discuss, a pulmonary-autograft or Ross strategy. Durability, anticoagulation, bleeding and clotting considerations, pregnancy plans when relevant, reintervention, anatomy, and program experience may all matter. The service does not select a valve or procedure.

The exact record depends on the question. It commonly includes source echocardiogram images and reports, prior comparable studies, and CT or MRI when the thoracic aorta or procedural anatomy needs clarification. Clinical notes, symptom history, laboratories, catheterization or coronary imaging, and the proposed plan may also be relevant. The records team can help identify what is needed after authorization.

Current aortic-disease guidance recommends transthoracic-echocardiographic screening of all first-degree relatives—parents, siblings, and children—when bicuspid valve occurs with root or ascending-aorta dilation, and says screening is reasonable even when associated aortic dilation is not yet known. CT or MRI may be used when echo assessment is incomplete. Each relative should discuss personal screening with their own clinician; WHITEGLOVEMD does not order or interpret family screening through this service.

A cardiac surgeon and cardiologist independently review the same complete record and imaging, confer, and co-sign one WHITEGLOVE Insights™ report. Both physician perspectives are included in every package.

The report is delivered within 24 hours only after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window. Do not delay urgent or time-sensitive care while waiting for a second opinion.

WHITEGLOVE Insights™ is $495, Consult is $995, Heart Team is $1,495, and Concierge is $2,495. Every package includes independent review by a cardiac surgeon and cardiologist, their conference, and one co-signed report. Higher levels add live physician time or concierge support. No referral or introductory call is required to purchase. The service is direct pay, and WHITEGLOVEMD does not submit an insurance claim.

No. WHITEGLOVEMD provides educational decision support and independent medical-record review. It does not establish a treating relationship, diagnose, prescribe, order testing, select a procedure, provide emergency care, or replace the clinicians responsible for your care. Do not delay urgent or time-sensitive treatment while seeking a review.